CNS relapse in DLBCL: a calculable risk?
- PMID: 33630050
- DOI: 10.1182/blood.2020009269
CNS relapse in DLBCL: a calculable risk?
Comment on
-
Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma.Blood. 2021 Feb 25;137(8):1120-1124. doi: 10.1182/blood.2020007236. Blood. 2021. PMID: 32877514 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources

